MENU
+Compare
AVXL
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$5.69
Change
-$1.21 (-17.54%)
Capitalization
488.74M

AVXL Anavex Life Sciences Corp Forecast, Technical & Fundamental Analysis

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need... Show more

Industry: #Biotechnology
AVXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AVXL with price predictions
Nov 12, 2025

AVXL sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AVXL moved below the 200-day moving average on October 17, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AVXL as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVXL turned negative on October 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

AVXL moved below its 50-day moving average on October 23, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AVXL entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVXL advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

AVXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.373) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AVXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVXL is expected to report earnings to fall 10.87% to -14 cents per share on December 22

Anavex Life Sciences Corp AVXL Stock Earnings Reports
Q3'25
Est.
$-0.14
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.02
The last earnings report on August 12 showed earnings per share of -15 cents, missing the estimate of -14 cents. With 8.75M shares outstanding, the current market capitalization sits at 488.74M.
A.I. Advisor
published General Information

General Information

a developer of innovative drug compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYRNX14.850.13
+0.88%
Lyrical International Value Equity Inv
BMCRX29.730.04
+0.13%
BlackRock Advantage Large Cap Gr R
RYSPX103.480.06
+0.06%
Rydex S&P 500 H
JLVIX78.890.05
+0.06%
JHancock Fundamental Large Cap Core I
FEATX61.25N/A
N/A
Fidelity Advisor Emerging Asia M

AVXL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.73%
PLRX - AVXL
48%
Loosely correlated
+7.78%
TENX - AVXL
47%
Loosely correlated
-0.71%
AXON - AVXL
45%
Loosely correlated
-0.47%
VCYT - AVXL
41%
Loosely correlated
-0.84%
ARRY - AVXL
41%
Loosely correlated
-8.69%
More